Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

Autor:	Hartlapp, I. 1, Valta-Seufzer, D. 1, Siveke, J.T. 2, 3, Algül, H. 4, Goekkurt, E. 5, Siegler, G. 6, Martens, U.M. 7, Waldschmidt, D. 8, Pelzer, U. 9, Fuchs, M. 10, Kullmann, F. 11, Boeck, S. 12, Ettrich, T.J. 13, Held, S. 14, Keller, R. 15, Anger, F. 16, Germer, C.T. 16, Stang, A. 17, Kimmel, B. 1, Heinemann, V. 12, Kunzmann, V. 1, ∗
Zdroj:	In ESMO Open August 2022 7(4)
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu